Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05761743
Glycemic Control, Type II Diabetes, Parathyroidectomy
Sponsor: The Cleveland Clinic
View on ClinicalTrials.gov
Summary
The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.
Official title: Evaluation of Glycemic Control and Changes in Skeletal Profile in Patients With Type II Diabetes Undergoing Parathyroidectomy for Primary Hyperparathyroidism
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2023-02-27
Completion Date
2026-02-01
Last Updated
2025-10-06
Healthy Volunteers
No
Interventions
DIAGNOSTIC_TEST
Urine and Blood Test
Urine N-telopeptide and serum osteocalcin
Locations (1)
Cleveland Clinic Main Campus
Cleveland, Ohio, United States